Reevaluating HIV vaccine clinical trials policy for infants

J Infect Dis. 2015 Feb 15;211(4):501-3. doi: 10.1093/infdis/jiu445. Epub 2014 Aug 27.

Authors

Glenda E Gray¹, Lawrence Corey²

Affiliations

¹ South African Medical Research Council Perinatal HIV Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa HIV Vaccine Trials Network, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
² HIV Vaccine Trials Network, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

PMID: 25170103
DOI: 10.1093/infdis/jiu445

No abstract available

Publication types

Editorial
Comment

MeSH terms

AIDS Vaccines / immunology*
HIV Antibodies / immunology*
HIV Envelope Protein gp120 / immunology*
HIV-1 / immunology*
Humans
Immunoglobulin A / immunology*
Immunoglobulin G / immunology*

Substances

AIDS Vaccines
HIV Antibodies
HIV Envelope Protein gp120
Immunoglobulin A
Immunoglobulin G

Grants and funding

UM1 AI068614/AI/NIAID NIH HHS/United States